By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BD Diagnostics, a division of Becton Dickinson, announced on Monday that it has filed an application with the US Food and Drug Administration for 510(k) clearance of the first fully automated molecular tests for herpes simplex virus types 1 and 2.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.